Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 29-34

  Nakanishi, Hiroshi ^b   Wang, Xiao Li ^b   Imai, Fabiana Lica ^b   Kato, Jiro ^b   Shiiba, Masashi ^b   Miya, Tsuneo ^b   Imai, Yutaka ^b   Tanzawa, Hideki ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Chromosome 9; Loss of heterozygosity (LOH); Oral squamous cell carcinoma (SCC); Tumor suppressor gene (TSG)

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ALPHA INTERFERON; PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; MOUTH CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TELOMERE; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERON-ALPHA; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MOUTH NEOPLASMS; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 0032919256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Devlin J, Keen AJ and Knowles A: Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Oncogene 9: 2757-2760, 1994.
3. Cannon ALA, Goldgat DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Patty EM, Bala AE, Olopade OI, Diaz MO, Kwiatkowski DJ, Piepkorn M, Zone JJ and Skolnick MH: Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258: 1148-1152, 1992.
4. Holmberg E, Rozell BL and Toftgard R: Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer. British of Cancer 74: 246-250, 1996.
5. Kamb A, Gruis NA, Weaver FJ, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in the genesis of many tumor types. Science 264: 436-440, 1994.
6. Nobori T, Miura K, Wu D, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin - dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.
7. Caldas C, Hahn SA, da Costa LT. Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo C and Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32, 1994.
8. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Shidransky D: 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
9. Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Bucker AJ and Louis DN: Mutational analysis of CDKN2(MTS1/P16ink4) in human breast carcinomas. Cancer Res 54: 5262-5264, 1994.
10. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y and Weaver-Feldhaus J: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8: 23-26, 1994.
11. Nakanishi H, Uzawa K, Yokoe H, Miya T, Wang XL, Watanabe T, Miyakawa A, Shiiba M, Sato T, Imai Y and Tanzawa H: Rare mutations of the growth suppressor genes involved in negative regulation of the cell cycle: p15, p16 and p18 genes in oral squamous cell carcinoma. Int J Oncol 11: 1129-1133, 1997.
12. Uzawa K, Suzuki H, Komiya A, Nakanishi H, Ogawara K, Tanzawa H and Sato K: Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer 67: 510-514, 1996.
13. WORLD HEALTH ORGANIZATION. International Histological Classification of Tumors, histological typing of oral and oropharyngeal tumors, No.4: WHO, 1971.
14. UICC, TNM Classification of malignant tumors. 4th ed., Springer, Berlin, Heideberg 16-18, 1987.
15. Komiya A, Suzuki H, Aida S, Yatani R and Shimazaki J: Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissue and cell lines of human prostate cancer. Jpn J Cancer Res 86: 622-625, 1995.
16. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1146, 1991.
17. Merlo A, Gabrielson E, Askin F and Shidransky D: Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54: 640-642, 1994.
18. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK and Mao L: Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 57: 400-403, 1997.
19. Cannon ALA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Patty EM, Bala AE, Olopade OI, Diaz MO, Kwiatkowski DJ, Piepkorn M, Zone JJ and Skolnick MH: Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258: 1148-1152, 1992.
20. Van DRP, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W and Sidransky D: Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54: 1156-1158, 1994.
21. Ishwad CS, Ferrell RE, Rossie KN, Appel BN, Johnson JT, Myers EN, Law JC, Srivastava S and Gollin SM: Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer 69: 1-4, 1996.
22. Devlin J, Keen AJ and Knowles A: Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Oncogene 9: 2757-2760, 1994.
23. Farndon PA, Del Mastro RG, Evans DG and Kilpatrick MW: Location of gene for Gorlin syndrome. Lancet 339: 581-582, 1992.
24. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E and Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B and Bale AE: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-51, 1996.